Q: What is Wilate used for?

Wilate is used to treat von Willebrand disease and hemophilia A .

Q: How does Wilate work?

Mechanism of Action Wilate is a concentrate made from human plasma that contains two important blood-clotting proteins: von Willebrand Factor (VWF) and Coagulation Factor VIII. These proteins work together to help the blood form clots and stop bleeding. The Role of von Willebrand Factor In a healthy body, von Willebrand Factor performs two primary functions: Platelet Adhesion: It acts like a bridge, helping tiny blood cells called platelets stick to the site of a blood vessel injury. Protein Protection: It binds to Factor VIII, protecting it from being broken down prematurely in the bloodstream. For people with von Willebrand disease, Wilate replaces the missing or poorly functioning VWF, allowing platelets to stick to injured areas and stabilize the clotting process. The Role of Factor VIII Factor VIII is a protein that triggers a chain reaction in the blood to form a firm clot. In people with Hemophilia A, this protein is missing or not working correctly. Wilate provides the necessary Factor VIII to complete the clotting process and prevent or stop bleeding episodes.

Q: What are the active ingredients in Wilate?

The active ingredients in Wilate are von Willebrand factor and factor VIII .

Q: What are the side effects of Wilate?

Common side effects of Wilate may include: headache nausea dizziness Always consult with a healthcare professional about potential side effects.

Q: What is the dosage of Wilate and how do I take it?

Administration Wilate is administered through an intravenous (IV) infusion. It may be given by a healthcare professional in a medical setting, or patients and caregivers may be trained to administer the medication at home. Preparation This medication comes as a powder that must be mixed with a specific liquid (diluent) before use. General steps for preparation include: Bringing the powder and the diluent to room temperature before mixing. Gently swirling the vial to dissolve the powder; do not shake the vial. Checking the solution for particles or discoloration. The liquid should be clear or slightly opalescent. Using the solution immediately after mixing, as it does not contain preservatives. Dosing Schedule The frequency and duration of treatment are determined by a healthcare provider. Dosing patterns vary depending on whether the medication is used to treat an active bleed, prevent bleeding during surgery, or as routine prophylaxis to prevent bleeding episodes. The schedule is often based on the patient's weight and the severity of their condition. Missed Dose If a dose is missed, contact a healthcare provider or a specialized treatment center immediately for instructions. Do not use extra medication to make up for a missed dose.

Q: Is Wilate safe during pregnancy and breastfeeding?

Pregnancy Animal reproduction studies have not been conducted with Wilate. It is currently unknown whether this medication can cause harm to an unborn baby or affect a person's ability to conceive. Because of the lack of clinical data, Wilate should be administered to a pregnant woman only if the potential benefits outweigh the risks and it is clearly needed. Breastfeeding It is not known whether the components of Wilate pass into human breast milk. Because many drugs are excreted in human milk, caution should be exercised when this medication is administered to someone who is nursing. Healthcare providers typically evaluate the importance of the drug to the mother when deciding whether to continue or discontinue breastfeeding during treatment. Consult Your Healthcare Provider If you are pregnant, planning to become pregnant, or are breastfeeding, discuss your treatment options with your doctor. They can help evaluate the risks and benefits of using Wilate based on your specific medical needs and the severity of your condition.

Q: What forms and strengths does Wilate come in?

Dosage Form Wilate is supplied as a lyophilized (freeze-dried) powder for solution. It is intended for intravenous injection only after it has been reconstituted with the provided sterile water. Kit Components This medication is typically distributed in a kit containing the materials needed for a single administration. The kit generally includes: A vial containing the medication in powder form. A vial of sterile water for injection, which acts as the diluent. A needleless transfer device used to mix the liquid into the powder vial. The powder must be completely dissolved before use. The resulting solution should be clear or slightly pearlescent; it should not be used if it is cloudy or contains visible particles.

Q: What is the FDA approval status of Wilate?

FDA Approval and Indications Wilate was approved by the U.S. Food and Drug Administration (FDA) as a freeze-dried concentrate of human von Willebrand factor (VWF) and coagulation factor VIII (FVIII). It is authorized for use in both pediatric and adult patients for the following indications: von Willebrand Disease (VWD): For the on-demand treatment and control of bleeding episodes, and for the perioperative management of bleeding in patients with VWD. Hemophilia A: For the on-demand treatment and control of bleeding episodes, and for the perioperative management of bleeding in patients with hemophilia A. Regulatory Safety Information There are no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) currently required for Wilate. As a product derived from human plasma, it carries standard regulatory warnings regarding the potential risk of transmitting infectious agents, such as viruses and the variant Creutzfeldt-Jakob disease (vCJD) agent. This risk is mitigated through donor screening and viral inactivation and removal steps during the manufacturing process. Regulatory labeling also includes warnings regarding hypersensitivity reactions and the potential development of neutralizing antibodies (inhibitors) against VWF or FVIII. Patients and providers are advised to monitor for these conditions during treatment.

Question 1

What is Wilate?

Accepted Answer

Wilate is a sterile concentrate made from human plasma that contains two vital blood-clotting proteins: von Willebrand factor and coagulation factor VIII. These proteins work together in the body to help form blood clots and prevent excessive bleeding. This therapy functions by replacing these specific factors to support the body's natural coagulation process.

Question 2

What is Wilate used for?

Accepted Answer

Wilate is used to treat von Willebrand disease and hemophilia A.

Question 3

How does Wilate work?

Accepted Answer

Mechanism of Action

Wilate is a concentrate made from human plasma that contains two important blood-clotting proteins: von Willebrand Factor (VWF) and Coagulation Factor VIII. These proteins work together to help the blood form clots and stop bleeding.

The Role of von Willebrand Factor

In a healthy body, von Willebrand Factor performs two primary functions:

Platelet Adhesion: It acts like a bridge, helping tiny blood cells called platelets stick to the site of a blood vessel injury.
Protein Protection: It binds to Factor VIII, protecting it from being broken down prematurely in the bloodstream.

For people with von Willebrand disease, Wilate replaces the missing or poorly functioning VWF, allowing platelets to stick to injured areas and stabilize the clotting process.

The Role of Factor VIII

Factor VIII is a protein that triggers a chain reaction in the blood to form a firm clot. In people with Hemophilia A, this protein is missing or not working correctly. Wilate provides the necessary Factor VIII to complete the clotting process and prevent or stop bleeding episodes.

Question 4

What are the active ingredients in Wilate?

Accepted Answer

The active ingredients in Wilate are von Willebrand factor and factor VIII.

Question 5

What are the side effects of Wilate?

Accepted Answer

Common side effects of Wilate may include:

headache
nausea
dizziness

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Wilate?

Accepted Answer

Wilate belongs to the clotting factor replacement drug class.

Question 7

What is the dosage of Wilate and how do I take it?

Accepted Answer

Administration

Wilate is administered through an intravenous (IV) infusion. It may be given by a healthcare professional in a medical setting, or patients and caregivers may be trained to administer the medication at home.

Preparation

This medication comes as a powder that must be mixed with a specific liquid (diluent) before use. General steps for preparation include:

Bringing the powder and the diluent to room temperature before mixing.
Gently swirling the vial to dissolve the powder; do not shake the vial.
Checking the solution for particles or discoloration. The liquid should be clear or slightly opalescent.
Using the solution immediately after mixing, as it does not contain preservatives.

Dosing Schedule

The frequency and duration of treatment are determined by a healthcare provider. Dosing patterns vary depending on whether the medication is used to treat an active bleed, prevent bleeding during surgery, or as routine prophylaxis to prevent bleeding episodes. The schedule is often based on the patient's weight and the severity of their condition.

Missed Dose

If a dose is missed, contact a healthcare provider or a specialized treatment center immediately for instructions. Do not use extra medication to make up for a missed dose.

Question 8

Is Wilate safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Animal reproduction studies have not been conducted with Wilate. It is currently unknown whether this medication can cause harm to an unborn baby or affect a person's ability to conceive. Because of the lack of clinical data, Wilate should be administered to a pregnant woman only if the potential benefits outweigh the risks and it is clearly needed.

Breastfeeding

It is not known whether the components of Wilate pass into human breast milk. Because many drugs are excreted in human milk, caution should be exercised when this medication is administered to someone who is nursing. Healthcare providers typically evaluate the importance of the drug to the mother when deciding whether to continue or discontinue breastfeeding during treatment.

Consult Your Healthcare Provider

If you are pregnant, planning to become pregnant, or are breastfeeding, discuss your treatment options with your doctor. They can help evaluate the risks and benefits of using Wilate based on your specific medical needs and the severity of your condition.

Question 9

What forms and strengths does Wilate come in?

Accepted Answer

Dosage Form

Wilate is supplied as a lyophilized (freeze-dried) powder for solution. It is intended for intravenous injection only after it has been reconstituted with the provided sterile water.

Kit Components

This medication is typically distributed in a kit containing the materials needed for a single administration. The kit generally includes:

A vial containing the medication in powder form.
A vial of sterile water for injection, which acts as the diluent.
A needleless transfer device used to mix the liquid into the powder vial.

The powder must be completely dissolved before use. The resulting solution should be clear or slightly pearlescent; it should not be used if it is cloudy or contains visible particles.

Question 10

What is the FDA approval status of Wilate?

Accepted Answer

FDA Approval and Indications

Wilate was approved by the U.S. Food and Drug Administration (FDA) as a freeze-dried concentrate of human von Willebrand factor (VWF) and coagulation factor VIII (FVIII). It is authorized for use in both pediatric and adult patients for the following indications:

von Willebrand Disease (VWD): For the on-demand treatment and control of bleeding episodes, and for the perioperative management of bleeding in patients with VWD.
Hemophilia A: For the on-demand treatment and control of bleeding episodes, and for the perioperative management of bleeding in patients with hemophilia A.

Regulatory Safety Information

There are no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) currently required for Wilate. As a product derived from human plasma, it carries standard regulatory warnings regarding the potential risk of transmitting infectious agents, such as viruses and the variant Creutzfeldt-Jakob disease (vCJD) agent. This risk is mitigated through donor screening and viral inactivation and removal steps during the manufacturing process.

Regulatory labeling also includes warnings regarding hypersensitivity reactions and the potential development of neutralizing antibodies (inhibitors) against VWF or FVIII. Patients and providers are advised to monitor for these conditions during treatment.

Question 11

What should I know about Wilate and cost?

Accepted Answer

Factors Influencing Cost

Wilate is a specialty biologic medication, and its price is typically based on the number of International Units (IU) prescribed. Several factors can affect the total cost of treatment:

Dosage and Weight: Because dosing is often based on body weight and the severity of the clotting factor deficiency, larger doses will increase the price per treatment.
Treatment Frequency: Patients using Wilate for routine prophylaxis (prevention of bleeding) will generally have higher overall costs than those using it only on-demand for acute bleeding episodes.
Vial Strength: Wilate is supplied in kits containing different strengths, such as 500 IU or 1000 IU vials, which are priced accordingly.

Insurance and Financial Assistance

Most health insurance plans, including Medicare and Medicaid, provide coverage for Wilate when it is medically necessary for von Willebrand disease or Hemophilia A. However, patients may still be responsible for out-of-pocket costs, such as deductibles, co-payments, or co-insurance.

Because it is a specialty drug, Wilate is usually obtained through specialty pharmacies rather than standard retail locations. The manufacturer may offer patient assistance programs or co-pay savings cards to help eligible individuals manage their out-of-pocket expenses.

Wilate

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

Found an Error?

Find Discounts for Wilate

Hospitals.net Disclosure